FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
January 06, 2023 at 14:11 PM EST
The FDA's decision comes after clinical trial results indicated that lecanemab slows cognitive decline somewhat in people with mild impairment from Alzheimer's.
